What if I Already Took My 2020 RMD?
The new stimulus plan suspends required minimum distributions for 2020. Contributor Natalie Choate offers advice to early birds who've already taken RMDs for the year.
The CARES Act suspends required minimum distributions, or RMDs, for the year 2020 for all qualified retirement plans and IRAs. Presumably this component of the stimulus bill is intended to help retirees and beneficiaries who would otherwise be forced to take 2020 RMDs that were computed based on the bloated market values of Dec. 31, 2019, from retirement plans whose value was smashed by the coronavirus-triggered market plunge in 2020.
So, this one's easy, right? Just don't take an RMD in 2020 and move on to 2021. The devil is in the details that advisors will need to wrestle with, though. We can probably look back to the prior one-year suspension of RMDs (in 2009) to predict how this one will work.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.